J&J Has No Plans to Enter Obesity Drugs Market, CEO Says (opens original article in a new tab)

J&J CEO says the company is not entering the obesity market and will focus on diseases like cancer instead.

• J&J CEO says company has no plans to enter the obesity market
• J&J will focus on diseases like cancer instead
• Company is different from many others in the healthcare sector